Table 3.
Clinical characteristics of patients with and without major adverse cardiac events (MACE) within six months of follow up
| MACE (n = 18) | No MACE (n = 101) | p Value | |
| Age (years) | 61 (10) | 62 (11) | 0.574* |
| Men (%) | 78% | 74% | 1.0† |
| Risk factors | |||
| Hypertension | 83% | 78% | 0.761† |
| Diabetes | 39% | 24% | 0.242† |
| Smoking | 28% | 40% | 0.498† |
| Family history | 33% | 40% | 0.827† |
| Hypercholesterolaemia | 94% | 81% | 0.403† |
| Prior MI | 56% | 57% | 1.0† |
| Restenotic lesion | 11% | 12% | 0.831† |
| Unstable angina | 44% | 26% | 0.15† |
| Vessel involvement | 0.133‡ | ||
| 1 vessel disease | 17% | 21% | |
| 2 vessel disease | 17% | 36% | |
| 3 vessel disease | 67% | 44% | |
| Lesion type | 0.483‡ | ||
| Type A | 25% | 22% | |
| Type B1 | 0% | 14% | |
| Type B2 | 44% | 36% | |
| Type C | 31% | 28% |
*t Test for unpaired samples; †Fisher exact test; ‡Mann-Whitney-Wilcoxon U test.